Hsbc Holdings PLC bought a new stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 4,879 shares of the scientific and technical instruments company's stock, valued at approximately $519,000. Hsbc Holdings PLC owned approximately 0.05% of Transcat as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the stock. MetLife Investment Management LLC lifted its stake in Transcat by 10.6% during the fourth quarter. MetLife Investment Management LLC now owns 5,430 shares of the scientific and technical instruments company's stock worth $574,000 after purchasing an additional 519 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Transcat by 5.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 209,200 shares of the scientific and technical instruments company's stock worth $22,121,000 after buying an additional 10,186 shares during the last quarter. First Trust Advisors LP boosted its holdings in shares of Transcat by 133.4% in the 4th quarter. First Trust Advisors LP now owns 153,196 shares of the scientific and technical instruments company's stock valued at $16,199,000 after buying an additional 87,568 shares during the period. Champlain Investment Partners LLC grew its position in shares of Transcat by 35.7% during the 4th quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company's stock valued at $58,754,000 after buying an additional 146,150 shares during the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in Transcat during the fourth quarter worth about $9,460,000. 98.34% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of brokerages have recently weighed in on TRNS. Northland Securities reiterated a "market perform" rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Oppenheimer cut Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. HC Wainwright lowered their price target on shares of Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research report on Wednesday, January 29th. Finally, StockNews.com downgraded shares of Transcat from a "hold" rating to a "sell" rating in a research report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $111.50.
View Our Latest Research Report on TRNS
Transcat Stock Performance
Shares of NASDAQ TRNS traded up $3.92 during midday trading on Monday, reaching $82.64. 2,066 shares of the company traded hands, compared to its average volume of 76,472. The company has a market cap of $769.25 million, a price-to-earnings ratio of 44.92 and a beta of 0.69. The stock has a 50-day moving average price of $76.85 and a 200 day moving average price of $90.80. Transcat, Inc. has a 52 week low of $67.56 and a 52 week high of $147.12. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98.
About Transcat
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
